Pure μ-opioids (methadone, morphine, hydromorphone) provide profound analgesia and are preferred for extensive dental procedures. Partial agonists (buprenorphine) are suitable for moderate pain.

Eisai has filed to extend the label for its Alzheimer’s disease therapy Leqembi to include a maintenance dosing regimen that would reduce the number of intravenous infusions needed to one per month.

Parnell is proud to announce the launch of its new Isoflurane Inhalation Anesthetic, a nonflammable and nonexplosive solution designed for the induction and maintenance of general anesthesia in horses ...